Nova MSC Berhad has signed a Memorandum of Understanding with the Association of Malaysian Optometrists and Rhazes Consultancy Services Sdn Bhd, to bring its AI Deep Learning Technology, SELENA+ to mainstream adoption in Malaysia. Under the collaboration, EyRIS' AI deep learning technology, SELENA+, will be deployed to AMO's more than 1,000 members across Malaysia via RHAZES Telehealth. RHAZES Telehealth is Malaysia's first knowledge-based telehealth service provider through its brand Rhazes TeleOpto.

SELENA+ is capable of detecting up to 3 retinal diseases, principally diabetic retinopathy, glaucoma suspect and age-related macular degeneration. Early screening and detection of these diseases can significantly reduce vision loss, and in the case of diabetic retinopathy, studies have shown that diabetes-related vision loss can be reduced by up to 47%. EyRIS' SELENA+ has been approved for use by the Malaysian Medical Device Authority since 22nd June 2020.